Tapentadol and Metabolite, Random, Urine
Use
Monitoring of compliance utilizing tapentadol; detection and confirmation of illicit use of tapentadol. Not intended for employment-related testing.
Special Instructions
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen. Includes Clinical Toxicology CPT Code Client Guidance PDF.
Limitations
Urine concentrations do not correlate well with serum drug levels and are not intended for therapeutic drug management. Results are intended to be interpreted by a physician or other healthcare professional.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 101401-8
- 65807-0
- 65808-8
Result Turnaround Time
2-6 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plastic urine container; submission in plastic vial
Collection Instructions
Collect a random urine specimen. No preservative.
Causes for Rejection
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |